CN105125767A - Traditional Chinese medicine for treating pinkeye - Google Patents

Traditional Chinese medicine for treating pinkeye Download PDF

Info

Publication number
CN105125767A
CN105125767A CN201510575515.9A CN201510575515A CN105125767A CN 105125767 A CN105125767 A CN 105125767A CN 201510575515 A CN201510575515 A CN 201510575515A CN 105125767 A CN105125767 A CN 105125767A
Authority
CN
China
Prior art keywords
radix
herba
chinese medicine
traditional chinese
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510575515.9A
Other languages
Chinese (zh)
Inventor
贾红艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510575515.9A priority Critical patent/CN105125767A/en
Publication of CN105125767A publication Critical patent/CN105125767A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the field of traditional Chinese medicinal formulations, in particular to traditional Chinese medicine for treating pinkeye. The traditional Chinese medicine is characterized by comprising, by weight, 6-9% of scouring rush, 11-14% of tribulus terrestris, 10-13% of groundsel, 4-6% of cassia seeds, 5-8% of pipewort, 1-2% of kalopanax septemlobus, 6-8% of the root of Chinese coriaria, 4-7% of great burdock achene, 2-4% of the root of Chinese thorowax, 3-5% of rhizoma cimicifugae, 2-5% of duckweeds, 2-4% of felwort, 3-5% of platycodon grandiflorum, 2-4% of the root of three-nerved spicebush, 3-5% of asarum, 5-7% of forsythia, 6-9% of vervain and 2-4% of radix sileris. The raw medicinal materials are soaked in water, and dregs are removed after decoction to obtain a filtrate. The traditional Chinese medicine is low in cost, capable of effectively treating the pinkeye and free of toxic and side effects.

Description

The Chinese medicine for the treatment of pink eye disease
Technical field
The present invention relates to a kind of Chinese patent medicine preparation, specifically a kind of Chinese medicine for the treatment of pink eye disease.
Background technology
As everyone knows, modern medicine claims pink eye disease to be acute conjunctivitis, and the traditional Chinese medical science is named again " acute and chronic conjunctivitis ", is a kind of acute infectious disease caused by viral communication, its have morbidity anxious, propagate fast, popular wide, feature that infectiousness is strong.Clinically, primary disease is sent out red with urgency of falling ill, the supercilious look, ophthalmalgia, eyelid are swelled, order heat keeps in dark place, discharge of eye is many and be bonded as feature.Be mainly in spring, be ephemeral infectious disease, its route of transmission is mainly communicated by contact.Often through contact patient's eyes secretions or shake hands with blood-shot eye illness patient or to rub one's eyes etc. with dirty hands infected.
Summary of the invention
The object of the invention is exactly that provide a kind of Chinese medicine for the treatment of pink eye disease, cost is low, effectively can treat pink eye disease, have no side effect in order to overcome above-mentioned existing technical deficiency.
The technical scheme that the present invention solves the problems of the technologies described above employing is: a kind of Chinese medicine for the treatment of pink eye disease, it is characterized in that being made up of the crude drug of following percentage by weight: Herba Equiseti Hiemalis 6 ~ 9%, Fructus Atriplicis Sibiricae 11 ~ 14%, Herba Senecionis Scandentis 10 ~ 13%, Semen Cassiae 4 ~ 6%, Flos Eriocauli 5 ~ 8%, Kalopanax septemlobus (Thunb.) Kondz. 1 ~ 2%, Radix Coriariae Sinicae 6 ~ 8%, Fructus Arctii 4 ~ 7%, Radix Bupleuri 2 ~ 4%, Rhizoma Cimicifugae 3 ~ 5%, Herba Spirodelae 2 ~ 5%, Radix Gentianae 2 ~ 4%, Radix Platycodonis 3 ~ 5%, the Radix Linderae 2 ~ 4%, Herba Asari 3 ~ 5%, Fructus Forsythiae 5 ~ 7%, Herba Verbenae 6 ~ 9%, Radix Saposhnikoviae 2 ~ 4%, by medicinal for above-mentioned raw materials water soaking, to remove slag after decocting to obtain filtrate.
The invention has the beneficial effects as follows, all medicines share, and cost is low, effectively can treat pink eye disease, have no side effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described:
Embodiment 1:
Herba Equiseti Hiemalis, Fructus Atriplicis Sibiricae, Herba Senecionis Scandentis, Semen Cassiae, Flos Eriocauli, Kalopanax septemlobus (Thunb.) Kondz., Radix Coriariae Sinicae, Fructus Arctii, Radix Bupleuri, Rhizoma Cimicifugae, Herba Spirodelae, Radix Gentianae, Radix Platycodonis, the Radix Linderae, Herba Asari, Fructus Forsythiae, Herba Verbenae, Radix Saposhnikoviae is adopted to be that crude drug is prepared from.Its component (% by weight) is often paid as Herba Equiseti Hiemalis 8, Fructus Atriplicis Sibiricae 13, Herba Senecionis Scandentis 12, Semen Cassiae 6, Flos Eriocauli 7, Kalopanax septemlobus (Thunb.) Kondz. 2, Radix Coriariae Sinicae 7, Fructus Arctii 5, Radix Bupleuri 4, Rhizoma Cimicifugae 4, Herba Spirodelae 5, Radix Gentianae 3, Radix Platycodonis 3, the Radix Linderae 3, Herba Asari 4, Fructus Forsythiae 5, Herba Verbenae 6, Radix Saposhnikoviae 3.Getting above-mentioned 18 taste crude drug gross weights is 250 grams, add water about 1000ml, soaks 4 ~ 5 hours, boil rear slow fire and decoct 80 ~ 90 minutes, remove slag to obtain filtrate about 200ml, medicinal residues add water 200 ~ 300ml again, and decoct 30 ~ 40 minutes, remove slag to obtain filtrate about 100ml, be total to obtain about 300ml medicine juice, i.e. obtained decoction, load in sterile glass vials, seal bottle cap is for subsequent use.Every day 1 dose point 2 times is oral, each (medicine) being taken before meal about 150ml.
Herba Equiseti Hiemalis liver heat removing and eyesight improving of the present invention, hemostasis, inducing diuresis for treating stranguria syndrome, main anemopyretic cold, cough, conjunctival congestion and swelling pain, nebula; Fructus Atriplicis Sibiricae suppressing the hyperactive liver resolving depression, dispelling pathogenic wind for improving eyesight.For dizziness due to hyperactivity of liver-YANG headache, hypochondriac pain due to stagnation of liverQI, headache due to pathogenic wind-heat, conjunctival congestion and swelling pain, the diseases such as skin pruritus; The effects such as Herba Senecionis Scandentis has heat-clearing and toxic substances removing, improving eyesight, antipruritic.Be used for anemopyretic cold, conjunctival congestion and swelling pain; Semen Cassiae is used for the puckery pain of conjunctival congestion, and the many tear of photophobia, has a headache dizzy, poor vision, constipation; Flos Eriocauli has dispelling wind and heat pathogens, effect of improving acuity of vision and removing nebula.For the disease such as wind-heat of liver channel, conjunctival congestion and swelling pain, order raw cataracta, headache due to pathogenic wind-heat, nyctalopia; Kalopanax septemlobus (Thunb.) Kondz. removing toxic substances and promoting subsidence of swelling, dispelling wind for relieving itching; Radix Coriariae Sinicae cures mainly rheumatic numbness, acute toothache, phlegm retention, mass in the abdomen, scrofula, injury from falling down, acute conjunctivitis; Fructus Arctii has dispelling wind and heat pathogens, lung qi dispersing rash, sore-throat relieving eliminating stagnation, effect of removing toxic substances and promoting subsidence of swelling; Radix Bupleuri has reconciling superficies and interior, effect of soothing the liver yang invigorating; Rash delivered by Rhizoma Cimicifugae, heat-clearing and toxic substances removing, ascending up spleen-Qi and Yang; Herba Spirodelae diaphoresis rash, clearing away heat and promoting diuresis, cure mainly the diseases such as pathogenic factor in the exterior heating, measles, edema; Radix Gentianae heat clearing and damp drying, eliminating pathogen in the liver is calmed the frightened.Jaundice due to damp-heat, the feeling of fullness in the head headache of liver and gall excess-fire, conjunctival congestion and swelling pain; Radix Platycodonis lung qi dispersing, sore-throat relieving, eliminates the phlegm, evacuation of pus.For cough with copious phlegm, uncomfortable in chest not smooth, pharyngalgia; Radix Linderae promoting the circulation of QI to relieve pain, warming kidney for dispelling cold; Herba Asari induces sweat cold expelling, and wind-expelling pain-stopping is sensible, warming the lung to resolve fluid-retention; Fructus Forsythiae heat clearing away, removing toxic substances, eliminating stagnation, detumescence.Control warm, erysipelas, macule, carbuncle and ulcer toxic swelling; Herba Verbenae has promoting blood circulation to remove blood stasis, removing toxic substances, diuretic, jaundice eliminating, effect of preventing the attack (or recurrence) of malaria; Radix Saposhnikoviae has expelling pathogenic wind from the body surface, removing dampness to relieve pain, effect of relieving convulsion.
The each raw material of the present invention also can the embodiment that mixes of ratio (percentage by weight) listed by according to the form below realize.Its processing technique is identical with embodiment 1.
The clinical trial carried out below in conjunction with my institute is described in further detail the present invention:
1. clinical data
Observe case totally 100 examples, be divided into two groups at random, treatment group 80 example, matched group 20 example.2 groups of physical data statistics, through statistical procedures, make it have comparability, difference that namely there are no significant (P > 0.05).
2. Therapeutic Method
2.1 matched groups: external sodium cromoglycate eye-drop, every day 4 times, each 1 ~ 2, patient with severe symptoms can be increased to 6 times, 1 week course for the treatment of.
2.2 treatment groups: take embodiment one Chinese medicine, every day 1 dose point 2 times is oral, each (medicine) being taken before meal about 150ml, 1 week course for the treatment of.
2.3 observation items: following all situation changes before and after treatment: itch, burning sensation, photophobia, sheds tears, secretions, red and swollen, and mill sense, upper tarsal conjunctiva cicatrix, nipple hypertrophy or folliculus, have a delicate constitution symptom.
2.4 statistical methods: adopt SPSS17.0 statistical software to analyze.
3. criterion of therapeutical effect and therapeutic outcome
3.1 criterions of therapeutical effect are with reference to criterion of therapeutical effect relevant in " disease of tcm judgement criterion of therapeutical effect ".
Recovery from illness: clinical symptoms all disappears, and test chamber inspection is normal.Take a turn for the better: clinical symptom relief, lab testing improvement or normal.Invalid: clinical symptoms is without being clearly better or increasing the weight of.
3.2 therapeutic outcome
Two groups of clinical therapeutic efficacies are in table 1.
The therapeutic effect analysis of two groups: treatment group and matched group all effectively can treat acute conjunctivitis; Treatment group cure rate has pole significant difference compared with matched group cure rate.Total effective rate of the present invention is 100%, and treatment group is significantly higher than matched group, has significant difference.And two groups of patients all do not find obvious adverse reaction.

Claims (1)

1. treat the Chinese medicine of pink eye disease for one kind, it is characterized in that being made up of the crude drug of following percentage by weight: Herba Equiseti Hiemalis 6 ~ 9%, Fructus Atriplicis Sibiricae 11 ~ 14%, Herba Senecionis Scandentis 10 ~ 13%, Semen Cassiae 4 ~ 6%, Flos Eriocauli 5 ~ 8%, Kalopanax septemlobus (Thunb.) Kondz. 1 ~ 2%, Radix Coriariae Sinicae 6 ~ 8%, Fructus Arctii 4 ~ 7%, Radix Bupleuri 2 ~ 4%, Rhizoma Cimicifugae 3 ~ 5%, Herba Spirodelae 2 ~ 5%, Radix Gentianae 2 ~ 4%, Radix Platycodonis 3 ~ 5%, the Radix Linderae 2 ~ 4%, Herba Asari 3 ~ 5%, Fructus Forsythiae 5 ~ 7%, Herba Verbenae 6 ~ 9%, Radix Saposhnikoviae 2 ~ 4%, by medicinal for above-mentioned raw materials water soaking, filtrate of removing slag after decocting to obtain.
CN201510575515.9A 2015-09-06 2015-09-06 Traditional Chinese medicine for treating pinkeye Pending CN105125767A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510575515.9A CN105125767A (en) 2015-09-06 2015-09-06 Traditional Chinese medicine for treating pinkeye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510575515.9A CN105125767A (en) 2015-09-06 2015-09-06 Traditional Chinese medicine for treating pinkeye

Publications (1)

Publication Number Publication Date
CN105125767A true CN105125767A (en) 2015-12-09

Family

ID=54711580

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510575515.9A Pending CN105125767A (en) 2015-09-06 2015-09-06 Traditional Chinese medicine for treating pinkeye

Country Status (1)

Country Link
CN (1) CN105125767A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1108130A (en) * 1994-12-15 1995-09-13 廖忠志 Herbal medicine prepn. for treating cataract and its prepn. method
CN1174068A (en) * 1997-07-14 1998-02-25 迟经惠 Medicine powder for nebula
CN1895291A (en) * 2006-06-09 2007-01-17 陈永丽 Nano-Chinese medicinal biological product and its preparation
CN101757305A (en) * 2008-11-28 2010-06-30 吴强 Traditional Chinese medicine for treating conjunctival congestion and sore pain
CN103768283A (en) * 2014-02-11 2014-05-07 高会玲 Traditional Chinese medicine for treating multiple eye diseases
CN104587076A (en) * 2015-01-13 2015-05-06 青岛市中心医院 Traditional Chinese medicine lotion for treating conjunctivitis

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1108130A (en) * 1994-12-15 1995-09-13 廖忠志 Herbal medicine prepn. for treating cataract and its prepn. method
CN1174068A (en) * 1997-07-14 1998-02-25 迟经惠 Medicine powder for nebula
CN1895291A (en) * 2006-06-09 2007-01-17 陈永丽 Nano-Chinese medicinal biological product and its preparation
CN101757305A (en) * 2008-11-28 2010-06-30 吴强 Traditional Chinese medicine for treating conjunctival congestion and sore pain
CN103768283A (en) * 2014-02-11 2014-05-07 高会玲 Traditional Chinese medicine for treating multiple eye diseases
CN104587076A (en) * 2015-01-13 2015-05-06 青岛市中心医院 Traditional Chinese medicine lotion for treating conjunctivitis

Similar Documents

Publication Publication Date Title
CN102579774B (en) Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes
CN102813823A (en) Traditional Chinese medicine composition for treating plane warts and application of traditional Chinese medicine composition
CN104288303A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
CN104189307A (en) Traditional Chinese medicine for treating deafness and tinnitus and preparation method thereof
CN103735907A (en) Traditional Chinese medicine for treating facial neuritis
CN107714760A (en) A kind of Chinese medicine preparation and preparation method for being used to treat acute mastitis
CN103432533B (en) Traditional Chinese medicine for treating perianal abscess
CN103505562B (en) For treating the Chinese medicine of keratitis
CN103446543B (en) Traditional Chinese medicine for treating thyroid associated ophthalmopathy in acute stage
CN102091239B (en) Uncaria abalone sour soup for treating trigeminal neuralgia
CN105125767A (en) Traditional Chinese medicine for treating pinkeye
CN104707098A (en) Internal drug for treating chronic blepharoconjunctivitis and preparation method of internal drug
CN104162028A (en) Traditional Chinese medicine decoction for treating trigeminal neuralgia
CN104398774A (en) Traditional Chinese drug for treating diabetic peripheral neuropathy
CN104524124A (en) Traditional Chinese medicinal preparation for treating skull osteomyelitis and preparation method
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN103638369B (en) Traditional Chinese medicinal preparation for treating mastitis
CN103877557B (en) A kind of Chinese medicine ointment and preparation method for the treatment of tinea unguium
CN102614357A (en) Preparation method of traditional Chinese medicine lotion for treating lumbago type lumbago
CN101537087A (en) Traditional Chinese medicine composition for treating retinal vein obstruction
CN105663785A (en) Traditional Chinese medicine composition for treating migraine and preparation method thereof
CN104997961A (en) Traditional Chinese medicine for treating acute mastitis
CN105194353A (en) Traditional Chinese medicine oral liquid for treating hypertension and preparation method
CN104258303A (en) Traditional Chinese medicine for treating dysmenorrhea
CN103272211A (en) Traditional Chinese medicine composite for treating hyperactivity of fire due to yin deficiency

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151209

WD01 Invention patent application deemed withdrawn after publication